Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
Lonza sharpens pharma focus...

Lonza sharpens pharma focus with CHF4.2B sale of Specialty Ingredients to Bain Capital and Cinven

10 Feb 2021
NutritionInsight Global EMEA
trans